Latest AI (Artificial Intelligence) News
Apple Abandons In-House LLMs, Partners with Google for AI
After two years of development, Apple has reportedly given up on building its own large language models to compete with ChatGPT, opting for a $1 billion annual partnership with Google to use Gemini instead. This move addresses shareholder concerns as iPhone sales slow and AI competition intensifies.
No official statement from Apple as of early 2026, but it signals reliance on external AI tech.
AI Agents Set to Transform Research Workflows in 2026
AI agents will automate massive data gathering, real-time hypothesis generation, and autonomous experimentation using digital twins and simulations. Recent breakthroughs include multi-agent collaboration solving complex problems and AI-generated papers passing peer review.
This shift from passive tools to active collaborators accelerates discoveries in medicine, climate, and tech.
Physicians Predict AI Will Accelerate Drug Development
Sermo poll shows 29% of physicians expect significant acceleration in drug development from AI, especially in target identification and drug-target predictions. AI scans genomic data and literature for causal links, reducing early failure rates.
As of February 2026, no FDA-approved AI-designed drugs yet, but optimism is high for clinical trials.
First AI-Designed Drug Completes Phase IIa Trials Successfully
In 2025, the first drug with AI-designed target and molecule showed dose-dependent improvements in idiopathic pulmonary fibrosis patients per Nature Medicine. It reached preclinical nomination in 18 months, vs. 3-4 years traditionally.
Advances in protein structure prediction boosted accuracy for DNA, RNA, and ligands.
New AI Model Speeds Up Antibody Drug Production by 76%
University of Oklahoma researchers developed an AI model that selects high-performing antibody clones correctly in 76.2% of trials and forecasts production from early data. Published in Communications Engineering, it addresses biomanufacturing bottlenecks for faster market entry.
The model enables simulated real-world clone selection.
Robot Industry Poised to Rival Automotive Sector Size with AI
Barron's Roundtable experts predict the humanoid robot industry could match the car business scale, driven by next-gen AI advancements. Discussions highlight robotics innovation, automation, and market potential in manufacturing.
This underscores AI's role in expanding robotics economically.
AI Ushers in New Epoch Across Tech, Medicine, and Culture in 2026
AI drives diagnostics, drug discovery, patient digital twins, and regulatory compliance in medicine, while raising privacy and bias risks. Transformations span media, fashion, and more, amplifying capacity and risks like deepfakes.
Ethical handling will define 2026's impact.